youtube_live
Q3 2026 earnings • in 3 days
See detailschevron_right
UHS:NYSE
Universal Health Services Inc
$186.89
arrow_downward
-0.66%(-1.24) 1D
$186.89
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 23, 4:00:02 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for UHS...
Open
$187.27
High
$188.98
Low
$186.56
Mkt. cap
11.01B
Avg. vol.
670.00K
Volume
450.80K
Dividend
0.43%
Quarterly dividend
$0.20
Ex-dividend date
Sep 1, 2026
P/E ratio
7.61
52-wk high
$246.32
52-wk low
$140.08
EPS
$24.56
Beta
1.03
Shares outstanding
51.69M
No. of employees
90K
Open
$187.27
High
$188.98
Low
$186.56
Mkt. cap
11.01B
Avg. vol.
670.00K
Volume
450.80K
Dividend
0.43%
Quarterly dividend
$0.20
Ex-dividend date
Sep 1, 2026
P/E ratio
7.61
52-wk high
$246.32
52-wk low
$140.08
EPS
$24.56
Beta
1.03
Shares outstanding
51.69M
No. of employees
90K
News stories
From web sources and news partners
UA.NEWS
·
23 hours ago
Dow Jones falls 1.2% amid concerns over AI spending — The Rio Times
BigGo Finance
·
7 hours ago
Dow Plunges 652 Points After Crude Oil Tops $100 on Renewed US-Iran War Fears
Traders Union
·
9 hours ago
Phil Rosen: S&P 500 turned $10,000 into $54,839 from 2005 to 2025 if best days held
Profile
Universal Health Services, Inc. is an American Fortune 500 company that provides hospital and healthcare services, based in King of Prussia, Pennsylvania. In 2024, UHS reported total revenues of $15.8 billion. Wikipedia
About Universal Health Services Inc
Analyst ratings
Based on 14 analysts giving stock ratings to UHS in the past 3 months
Hold
Buy
4
Hold
9
Sell
1
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for UHS in the last 3 months.
Highest
Current $186.89
$290.00 (+55.17%)
Average
$193.00 (+3.27%)
Lowest
$166.00 (-11.18%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Andrew Mok CFA Barclays | Hold | Maintained | $168.00 | -10.1% | 10/07/2026 |
Ben Hendrix RBC Capital | Hold | Maintained | $183.00 | -2.1% | 10/07/2026 |
John Ransom Raymond James | Hold | Reiterated | - | - | 09/28/2026 |
Whit Mayo Leerink Partners | Buy | Reiterated | $205.00 | +9.7% | 09/18/2026 |
Stephen Baxter Wells Fargo | Hold | Maintained | $166.00 | -11.2% | 09/08/2026 |
Benjamin Rossi J.P. Morgan | Hold | Maintained | $200.00 | +7% | 09/03/2026 |
A.J. Rice UBS | Buy | Reiterated | $290.00 | +55.2% | 08/31/2026 |
Kevin Fischbeck Bank of America Securities | Sell | Reiterated | $170.00 | -9% | 08/10/2026 |
Scott Fidel Goldman Sachs | Hold | Reiterated | $190.00 | +1.7% | 07/30/2026 |
Craig Hettenbach Morgan Stanley | Hold | Maintained | $191.00 | +2.2% | 07/29/2026 |
Jason Cassorla Guggenheim | Buy | Maintained | $189.00 | +1.1% | 07/28/2026 |
Michael Ha Robert W. Baird | Hold | Maintained | $166.00 | -11.2% | 07/29/2026 |
Ryan Langston TD Cowen | Buy | Reiterated | $197.00 | +5.4% | 07/29/2026 |
Sarah James Cantor Fitzgerald | Hold | Reiterated | $194.00 | +3.8% | 07/28/2026 |
Ann Hynes Mizuho Securities | Buy | Maintained | $200.00 | +7% | 07/13/2026 |
Next call in 3 days
Wed, Oct 28, 2:00 PM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $5.16
Revenue / Est. (USD)
- / 4.71B
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 4.50B | 4.49B | 4.50B | 4.64B |
Cost of goods sold | 2.49B | 2.47B | 2.51B | 2.56B |
Cost of revenue | 2.49B | 2.47B | 2.51B | 2.56B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 37.30M | 38.89M | 38.20M | 38.48M |
Operating expense | 1.49B | 1.50B | 1.48B | 1.56B |
Total operating expenses | 3.97B | 3.97B | 3.99B | 4.12B |
Operating income | 521.69M | 517.23M | 502.86M | 516.68M |
Other non operating income | 12.90M | 12.96M | 3.09M | 2.08M |
EBT including unusual items | 496.89M | 581.44M | 469.12M | 479.13M |
EBT excluding unusual items | 496.89M | 488.15M | 469.12M | 479.13M |
Income tax expense | 117.78M | 133.60M | 110.44M | 114.54M |
Effective tax rate | 23.70% | 22.98% | 23.54% | 23.91% |
Other operating expenses | 1.29B | 1.30B | 1.28B | 1.35B |
Net income | 372.96M | 445.94M | 348.68M | 358.45M |
Net profit margin | 8.30% | 9.94% | 7.76% | 7.73% |
Earnings per share | 5.69 | 5.88 | 5.62 | 5.98 |
Interest and investment income | 656.00K | 247.00K | 91.00K | 102.00K |
Interest expense | -38.62M | -42.46M | -37.22M | -40.01M |
Net interest expenses | -37.96M | -42.22M | -37.13M | -39.91M |
Depreciation and amortization charges | 155.06M | 163.33M | 155.43M | 167.34M |
EBITDA | 676.75M | 680.57M | 658.29M | 684.01M |
Gain or loss from assets sale | - | 5.14M | -5.05M | -532.00K |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1